ALA Expands Lung Cancer Clinical Trial Awareness
The American Lung Association initiative seeks to address mistrust, reduce disparities, and expand lung cancer trial participation among underrepresented patient populations.
The American Lung Association initiative seeks to address mistrust, reduce disparities, and expand lung cancer trial participation among underrepresented patient populations.
The American Lung Association initiative seeks to address mistrust, reduce disparities, and expand lung cancer trial participation among underrepresented patient populations.
Read MorePatients diagnosed with lung cancer demonstrated a higher prevalence and greater total burden of microplastics in their lungs compared to individuals without cancer.
Read MoreUCLA Health combines biopsy, staging, and surgery into a single session to reduce delays and improve lung cancer patient outcomes.
Read MorePopulation aging is driving an increase in lung cancer mortality in China despite improved prevention and treatment efforts.
Read MoreSpecific circular DNA features found in blood and tissue could help clinicians identify patients at high risk for recurrence after surgery.
Read MoreThe multicenter study will evaluate an artificial intelligence module designed for rapid tissue assessment during bronchoscopic procedures.
Read MoreOn World Lung Cancer Day, international organizations advocate for earlier detection and screening to reduce mortality from lung cancer.
Read MoreThree research teams are developing noninvasive, cost-effective screening tools to improve lung cancer detection rates among smokers and non-smokers.
Read MoreResearchers developed a system that redirects pre-existing antiviral signals to help the immune system recognize and attack cancer cells.
Read MoreZidesamtinib (Jideytro) is approved for patients with ROS1-positive non-small cell lung cancer who have previously received targeted therapy.
Read MoreNew research suggests that excess abdominal fat impairs the lung’s immune defenses, allowing non-small cell lung cancer to develop more rapidly.
Read MoreUT Southwestern Medical Center is the first healthcare provider in North Texas to offer single-port robotic-assisted thoracoscopic lobectomy, a minimally invasive procedure for select patients with early-stage lung cancer.
Read MoreRisk-based models may improve screening efficiency compared to current guidelines, but accuracy issues remain for specific racial and ethnic populations.
Read MoreThe MATCH 2 study reported a 96.7% overall diagnostic yield for peripheral lung nodules when using robotic-assisted bronchoscopy (RAB) with integrated imaging.
Read MoreResearchers identified an experimental antibody that targets a specific protein to shrink tumors in non-small cell lung cancer models.
Read MoreResearchers at Adelaide University developed a lipid-polymer vehicle that improves drug bioavailability and reduces systemic toxicity in preclinical models of lung cancer.
Read MoreA smart sensor integrated into a biopsy device helps clinicians identify cancerous tissue in real time to improve diagnostic results.
Read MoreA patient with advanced lung cancer and interstitial lung disease received a double-lung transplant through a clinical trial at Northwestern Medicine.
Read MoreResearchers have developed a new form of CRISPR technology that destroys harmful cells instead of editing their genes, while leaving healthy tissue untouched.
Read MoreA study found that YAP1 protein expression emerges after treatment, contributing to relapse in small cell lung cancer patients.
Read MoreNew research suggests that pesticide residues on fruits, vegetables, and whole grains may contribute to an increase in lung cancer cases among Americans under age 50 who have never smoked.
Read MoreA new computational biomarker uses existing biopsy slides to identify which patients will benefit from standard treatment before therapy begins.
Read MoreAn artificial intelligence tool called PhenopyCell can determine if patients with extensive-stage small cell lung cancer will benefit from chemotherapy using existing biopsy slides.
Read MoreUCLA study finds that small cell neuroendocrine tumors depend on a specific protein to grow, offering a potential path for new treatments.
Read More